This Open Access book is the second volume in a series on quantum technology governance. Volume II provides a systematic examination of governance frameworks, international standards, and ethical dimensions of quantum technologies. It offers a contribution to the ongoing discourse on quantum technology governance beyond law and regulation (considered in volume I). It is one of the first collections offering analyses to explore how quantum technology governance is shaped through international consensus standards-setting, frameworks, and normative principles that operate upstream of legislation and regulation, and can influence technological trajectories, interoperability, legitimacy, and trust. The contributions of the volume examine how developments in quantum computing and related applications reshape governance through layered interactions between technical architectures, consensus standards, institutional coordination, and ethical commitments. It highlights how international harmonized standards can function as de facto governance tools and how ethical considerations can be operationalized without technological exceptionalism, addressing questions of responsibility, fundamental rights, and societal impact. The volume aims to equip scholars, policymakers, standard-setters, and technologists with conceptual and analytical tools to navigate normative uncertainty, as well as manage governance systems across emerging quantum applications, including in high-stakes domains such as the life sciences. Overall, together with Volume I, the contributions aim to equip scholars, policymakers, and practitioners with insights to evaluate the interplay between technical design, regulation, standards, governance frameworks, and ethical considerations in the quantum era.
Mateo Aboy is Director of Research in Biomedical Innovation, AI, QT & Law at the Faculty of Law, University of Cambridge. He is a member of the Centre for Law, Medicine & Life Sciences (LML) and the Centre for IP & Information Law (CIPIL) at the University of Cambridge. He holds degrees in electrical & computer engineering (BS, BSEE, MSECE, MPhil/DEA, PhD ECE), law (LLB, SJD/PhD/LLD), and international management (MBA), as well as professional registrations as a Professional Chartered Engineer (CEng, EU/ES COIT), Certified Licensing Professional (CLP), Patent Practitioner with a Bar Admission/licensed to practice in patent cases before the United States Patent Office (USPTO), Fellow of Information Privacy (FIT, IAPP), Certified Privacy Information Professional (CIPP/E), Certified Privacy Manager (CIPM), Lead Implementer of Information Security Management Systems-ISMS (ISO 27001), Lead Auditor of Medical Device Quality Management Systems (ISO 13485), Lead Implementer of Privacy Information Management Systems - PIMS (ISO 27701), and Certified Data Protection Officer (C-DPO).
Marcelo Corrales Compagnucci is Associate Professor and Associate Director at the Center for Advanced Studies in Bioscience Innovation Law (CeBIL), Faculty of Law, University of Copenhagen in Denmark. He is also Inter-CeBIL Research Affiliate at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. He specializes in information technology, privacy, and data protection law. His research interests are the legal issues involved in disruptive innovation technologies and biomedicine. He wasa research associate with the Institute for Legal Informatics (IRI) at Leibniz Universität Hannover in Germany, and a visiting research fellow in various research centers around the world, including Harvard Law School, Cambridge University, the Max Planck Institute, University of Edinburgh, Turin University, and the Academia Sinica in Taiwan. He has a Doctor of Laws (LL.D.) degree from Kyushu University in Japan. He also holds a Master of Laws (LL.M.) in international economics and business law from Kyushu University, and an LL.M. in law and information technology and an LL.M. in European intellectual property law, both from the University of Stockholm in Sweden.
Timo Minssen is Professor of Law at the University of Copenhagen (UCPH). He holds the UNESCO Co-Chair in the Right to Science and is the Director of UCPH's Center for Advanced Studies in Bioscience Innovation Law (CeBIL). He is also an Inter-CeBIL Research Affiliate at Harvard Law School and at the University of Cambridge. His research and practice concentrates on IP-, Competition & Regulatory Law in emerging technologies, including the law and ethics of AI, quantum technologies, and health & life science innovation. Timo holds a German law degree from the University of Göttingen, and biotech & IP -related LL.M. M.I.C.L., LL.Lic. and LL.D. degrees from Lund & Uppsala University. He had been an Epigenetics fellow at the Pufendorf Institute for Advanced Studies, and a Visiting Professor at the Technical University of Munich, the Universities of Cambridge and Oxford, Waseda Law School, Harvard Law School, the Max Planck Institute for Innovation & Competition, and at the Chicago-Kent College of Law. Moreover, he was trained in the German Court system, the European Patent Office, law firms & start-ups. Timo serves as an advisor to the WHO, WIPO, OECD, the EU Commission, companies, national governments, and law firms. At UCPH he leads several interdisciplinary research projects on legal issues in emerging biotechnologies, precision medicine, ATMPs, antimicrobial resistance, pandemic preparedness, advanced medical computing, medical devices, and in sustainable innovation.
